BI, Dicerna to develop RNAi therapeutics for liver disease
admin 3rd November 2017 Uncategorised 0Boehringer Ingelheim has linked with US group Dicerna Pharmaceuticals to develop new RNAi therapeutics for liver diseases.
More: BI, Dicerna to develop RNAi therapeutics for liver disease
Source: News